Drug intelligence / Profile preview

Longzhong Injury Capsule

Development stage: Preclinical
Administration: Oral

Overview

Longzhong Injury Capsule (陇中损伤胶囊) is a traditional Chinese medicine (TCM) preparation in capsule form, developed and manufactured by Gansu Provincial Hospital of Traditional Chinese Medicine. It is primarily used for the treatment of traumatic injuries, including fractures, dislocations, and general contusions. The capsule is formulated with a combination of traditional Chinese medicinal ingredients, specifically Dragon bone, Eupolyphaga, and de-oiled Frankincense. Its therapeutic actions are aimed at relieving pain, promoting muscle regeneration, and enhancing blood circulation to aid in the recovery from injuries. It is administered orally.

Brand names: Longzhong injury capsuleLongzhong Shangke Jiaonang
Other names: 损伤胶囊Injury Capsule

Beyond the preview

Go deeper on Longzhong Injury Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Longzhong Injury Capsule.

Explore the full profile